Detalhe da pesquisa
1.
First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial.
Mol Ther
; 27(11): 1930-1938, 2019 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31570234
2.
Intratumoral Injection of HSV1716, an Oncolytic Herpes Virus, Is Safe and Shows Evidence of Immune Response and Viral Replication in Young Cancer Patients.
Clin Cancer Res
; 23(14): 3566-3574, 2017 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28495911